skip to primary navigationskip to content
 

Kevin Brindle's lab in new collaboration with MedImmune

last modified Apr 23, 2018 12:47 PM
AstraZeneca will contribute both funding and a post-doctoral scientist to the Brindle Group.

The global biologics research and development arm of AstraZeneca will contribute both funding and a post-doctoral scientist to work within the laboratory of Kevin Brindle in the area of tumour targeted therapies. Read the full story on the main University news web site.

Author


Jenny Barna

Publication Date


12 March 2014